Impulse control disorders in patients with pituitary tumors treated with dopamine agonists: a systematic review

R Hamblin, N Karavitaki - Archives of Medical Research, 2023 - Elsevier
Background The increased prevalence of Impulse Control Disorders (ICDs) in dopamine
agonist (DA) treated patients with Parkinson's disease is well described. Despite the …

Impulse control disorders in Parkinson's disease: a retrospective analysis of 1824 patients in a 12-year period

A Gunduz, T Çiftçi, AC Erbil, G Senoglu, MH Ser… - Neurological …, 2024 - Springer
Objective This study aims to clinically evaluate the impulse control disorders (ICDs)
encountered in treating Parkinson's disease. Method This is a retrospective analysis …

Treatment of hyperprolactinemia in women: A Position Statement from the Brazilian Federation of Gynecology and Obstetrics Associations (Febrasgo) and the …

CL Benetti-Pinto, AP Nácul… - … of Endocrinology and …, 2024 - SciELO Brasil
Dopamine agonists are the first line of treatment for patients with symptomatic
hyperprolactinemia due to prolactinomas and in those with idiopathic hyperprolactinemia …

[HTML][HTML] Hyperprolactinemia in women: treatment

CL Benetti-Pinto, AP Nácul… - Revista Brasileira de …, 2024 - SciELO Brasil
Background The treatment of HPRL, when necessary, is preferably carried out with DA,
generally for a prolonged period of time. There are particular situations in the female body …

[PDF][PDF] Impulse Control Disorders in Southern Iraqi Patients Medicated With Cabergoline for Prolactinoma

MM Mohammad, HA Alidrisi, AA Mansour, M Eydani - Cureus, 2024 - cureus.com
Background: Among the patient population in Basrah, Iraq, prolactinoma is the most
commonly found pituitary tumor. Impulse control disorders (ICDs) were reportedly …